dr. piotrowska on treatment for egfr-mutant nsclc
Published 4 years ago • 215 plays • Length 1:57Download video MP4
Download video MP3
Similar videos
-
1:23
dr. kujtan on frontline therapy for egfr-positive nsclc
-
4:41
upfront egfr-targeted therapy for nsclc
-
2:14
dr. yang on osimertinib as first-line therapy for egfr-positive nsclc
-
1:37
dr. yu on treatments for egfr-mutant lung cancer
-
1:37
dr. konduri on treatment options for patients with egfr-mutant nsclc
-
4:39
treatment for egfr nsclc
-
5:47
egfr tkis for upfront treatment of nsclc
-
0:34
fda approves rybrevant & lazcluze: new hope for advanced nsclc #shorts
-
9:01
emerging options for treatment of egfr-positive nsclc
-
1:25
current treatment recommendations and future directions for egfr-mutant nsclc
-
9:49
osimertinib as frontline therapy for egfr-positive nsclc
-
3:47
afatinib therapy for uncommon egfr alterations in nsclc
-
5:55
surgery options for nsclc & i-o therapy in egfr-mutations
-
0:58
dr. papadimitrakopoulou on treatment options for egfr-mutant nsclc
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
1:59
treatment options for egfr-positive lung cancer
-
5:00
options for up-front therapy in egfr-mutant nsclc
-
1:16
dr. wakelee on first-line therapy for egfr-mutant lung cancer
-
1:06
dr. goldman on targeted therapy options for egfr-, alk-, and ros1-mutated nsclc